COVID-19 VACCINATIONS: If, in addition to indemnity for your main employment, you would like cover for delivering COVID-19 Vaccinations please apply for our standalone extension Apply Today

Home  »   Latest News   »   PDA responds to Commission on Professional Leadership

PDA responds to Commission on Professional Leadership

The PDA has submitted a 17-page contribution to the commission on the future of pharmacy professional leadership and encourages pharmacists to engage in the overall discussion.

Wed 16th November 2022 The PDA

The future of the pharmacy profession’s leadership should be decided by pharmacists. The PDA is ensuring that the voice of its members is heard in the discussions about the future of professional leadership, which has been initiated by the four government Chief Pharmaceutical Officers.

The PDA has published its first formal contribution to the commission, which can be reviewed here.

thumbnail of Nov 2022 Commission Response – FINAL (live links)

The PDA’s response raises a number of points, including: 

• Concern that the current exercise is being rushed and a call for the review to be conducted in a more sensible timeframe, one which enables the engagement of the whole profession.
• Being supportive of the creation of a Royal College of Pharmacists to take custodianship of the training and education for pharmacists and to set the requisite standards, whilst still relying upon the profession’s regulators to undertake the accreditation role.
• The need to create a wider leadership arrangement that enables all credible pharmacy organisations to collaborate and provide leadership on common agenda issues, whilst allowing them to maintain their points of difference on other issues, as well as enabling them to continue to deliver separate and distinct functions.
• That the profession’s leadership structures need to be able to respond to a much wider agenda than just that of the four national governments and their NHS organisations.

Mark Koziol, PDA Chairman said, “The commission must recognise that anointing one body with the name ‘the professional leadership body’ does not and will not make it a leadership body.

“Leadership depends on the existence of ‘followers’ and if a body is to have followers, then it must be relevant to practitioners, making a beneficial difference to their lives.

“We believe that a Royal College of Pharmacists should be created which would focus upon the stewardship of education and training standards of practitioners at undergraduate and postgraduate level. With a narrower focus, the Royal College of Pharmacists could become more relevant to pharmacists by supporting the development of their future roles. As well as improving its chances of success, this would have the added benefit of resulting in a much lower membership fee.”

The PDA wants to continue hearing from its members with comments and ideas about the future of the profession’s leadership. To share any comments, please email the PDA at

Not yet a PDA member? 

If you have not yet joined the PDA, we encourage you to join today and ask your colleagues to do the same.

Membership is FREE to pharmacy students, trainee pharmacists, and for the first three months of being newly qualified.


Read about our key member benefits here.





The Pharmacists' Defence Association is a company limited by guarantee. Registered in England; Company No 4746656.

The Pharmacists' Defence Association is an appointed representative in respect of insurance mediation activities only of
The Pharmacy Insurance Agency Limited which is registered in England and Wales under company number 2591975
and is authorised and regulated by the Financial Conduct Authority (Register No 307063)

The PDA Union is recognised by the Certification Officer as an independent trade union.

Cookie Use

This website uses cookies to help us provide the best user experience. If you continue browsing you are giving your consent to our use of cookies.

General Guidance Resources Surveys PDA Campaigns Regulations Locums Indemnity Arrangements Pre-Regs & Students FAQs Coronavirus (COVID-19)